S. Faiss et al., INTERFERON-ALPHA VERSUS SOMATOSTATIN OR THE COMBINATION OF BOTH IN METASTATIC NEUROENDOCRINE GUT AND PANCREATIC TUMORS, Digestion, 57, 1996, pp. 84-85
Neuroendocrine tumours of the gastroenteropancreatic system represent
a therapeutic challenge. Current therapeutic strategies will be presen
ted and discussed with especial consideration given to biotherapeutic
regimens in metastatic tumour disease.